Clinical Trials Logo

Influenza H5N1 clinical trials

View clinical trials related to Influenza H5N1.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03651544 Completed - Influenza A Clinical Trials

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Start date: October 15, 2018
Phase: Phase 1
Study type: Interventional

The present clinical phase I study designed to examine the safety, reactogenicity and immunogenicity of the medicinal product - Vaccine vector against influenza A - in healthy volunteers after a single dose in the three groups with dose escalation.